Dover Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $281K | Sell |
2,222
-39
| -2% | -$4.93K | 0.12% | 140 |
|
|
2025
Q1 | $289K | Sell |
2,261
-357
| -14% | -$45.7K | 0.13% | 138 |
|
|
2024
Q4 | $346K | Hold |
2,618
| – | – | 0.2% | 99 |
|
|
2024
Q3 | $381K | Hold |
2,618
| – | – | 0.22% | 99 |
|
|
2024
Q2 | $359K | Sell |
2,618
-168
| -6% | -$23.1K | 0.22% | 98 |
|
|
2024
Q1 | $382K | Buy |
+2,786
| New | +$382K | 0.26% | 89 |
|
|
2023
Q4 | – | Sell |
-2,531
| Closed | -$310K | – | 89 |
|
|
2023
Q3 | $310K | Hold |
2,531
| – | – | 0.31% | 85 |
|
|
2023
Q2 | $321K | Hold |
2,531
| – | – | 0.29% | 81 |
|
|
2023
Q1 | $327K | Hold |
2,531
| – | – | 0.31% | 79 |
|
|
2022
Q4 | $332K | Buy |
+2,531
| New | +$332K | 0.36% | 75 |
|